Navigation Links
Columbus Cancer Foundation Honors Legendary Explorer
Date:10/9/2009

PHILADELPHIA, Oct. 9 /PRNewswire-USNewswire/ -- The Sbarro Health Research Organization (www.shro.org) at Temple University has launched the Columbus Cancer Foundation (www.columbuscancerfoundation.org), a nonprofit organization that will raise funds for joint American and European educational initiatives, basic and clinical cancer research and international scientific collaboration.

The name was chosen in honor of the courage and conviction with which Christopher Columbus embarked across unknown waters in the search of great discoveries.

"Today, great discoveries occur in laboratories around the world in response to the tragedy of cancer, a condition estimated to affect one out of every four individuals," says Antonio Giordano, M.D., Ph.D., the Founder and President of SHRO. "Fortunately, it is possible to understand, prevent and cure many types of cancer with the assistance of continued research funding which enables the discovery of genetically targeted diagnostic and therapeutic treatments."

"The primary goal of the Columbus Cancer Foundation is to stimulate clinical and laboratory cancer research that will ultimately enable us to develop personalized medicine techniques that will improve the survival and quality of life of cancer patients," explains Cora N. Sternberg, M.D., FACP, the Chairman of the Scientific Advisory Board. "Our mission is to develop, coordinate and conduct programs related to patient care, cutting edge research and education."

"There are many problems which need to be addressed in cancer treatment, including prevention, mechanisms of tumor development, the tumor environment, and mechanisms of response and resistance," says Sternberg. "Patient care will ultimately benefit from our increased understanding of the biology of cancer and possible therapeutic targets, their mechanisms of survival and overcoming resistance to therapy."

Donations to the new foundation can be made online at http://columbuscancerfoundation.org/.

An eminent American and Italian Medical Oncologist, Dr. Sternberg is currently the Chairman of the Department of Medical Oncology at San Camillo and Forlanini Hospitals in Rome, Italy, and a Professor at La Sapienza University in the Medical Oncology School of Specialization.

The Sbarro Health Research Organization is a nonprofit research center located at Temple University that conducts genetic and molecular research in cancer, diabetes, and cardiovascular disease. Based in Philadelphia, Pennsylvania, on the campus of Temple University, our programs train young scientists from around the globe.

This news release was issued on behalf of Newswise(TM). For more information, visit http://www.newswise.com.

SOURCE Sbarro Health Research Organization


'/>"/>
SOURCE Sbarro Health Research Organization
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Long Term Care Seminars in Dayton, Cleveland, Cincinnati, and Columbus -- Free to Public
2. Kenneth G. Langone, Home Depot Co-Founder, Chairman of the NYU Langone Medical Center, to Lead 65th Annual Columbus Day Parade as Grand Marshal
3. Knights of Columbus Gather in Phoenix for 127th International Convention
4. Aflac Outdoor Games Return to Columbus for a Second Year
5. Ohio Health Care Association/Ohio Centers for Assisted Living Host Midwests Largest Long-Term Care Convention in Columbus
6. Knights of Columbus Ultrasound Program Assists Pregnant Women
7. Irishman with Peripheral Arterial Disease (P.A.D.) Finds Leg-, Life-Saving Treatment In Columbus, Ohio
8. Columbus Medicare Diabetes Screening Project Cited as Model for State by Lt. Governor Casey Cagle
9. Streamline Health(R) Expands into Public Sector with New Customer, Columbus Public Health Vital Statistics Office
10. Kimberly-Clark Professional Donates Supplies to Assist Columbus, Ind., in Flood Cleanup Efforts
11. Ohio Health Care Association Hosts Midwests Largest Long-Term Care Convention in Columbus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... On Friday, ... presented a Bronze Wellness at Work award to iHire in recognition of their exemplary ... part of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort ... holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain ... Disease (SCD) is a disorder of the red blood cells, which can cause episodes ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. ... accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, ... and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its first-ever ... Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding work ... Practice and Pediatric Emergency Medicine Practice. , “With this award, we recognize ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... NAMUR , Belgium , ...  (NYSE MKT: VNRX), today announced the appointment of ... Board of Directors as a Non-Executive Director, effective ... the Company,s Audit, Compensation and Nominations and Governance ... Board, Dr. Futcher will provide independent expertise and ...
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... report to their offering. ... a favourable commercial environment for MedImmune to enter. The US ... will serve to drive considerable growth for effective anti-influenza medications. ... cap sales considerably, but development is still in its infancy. ...
Breaking Medicine Technology: